Becarbon pills №10×2

Name Bekarbon tab. in blister. in pack No. 20 Basic physical and chemical properties Round tablets from light brown to yellowish brown in color with patches, with beveled edges and a notch and with a characteristic weak specific odor. Composition active ingredients: thick belladonna extract, sodium bicarbonate; 1 tablet contains thick belladonna extract (Belladonnae extractum spissum) – hydroalcoholic ((4.8-5.2): 1) (extractant 20% (v / v) ethanol) extract, containing 1.5% of the amount of alkaloids, in terms of atropine base (hyoscyamine) and dry matter – 10 mg, sodium bicarbonate – 300 mg; excipients: corn starch, anhydrous colloidal silicon dioxide, magnesium stearate. Pharmacotherapeutic group Means based on belladonna and its derivatives. ATC code A03B. Indications for use Symptomatic treatment of functional disorders of the gastrointestinal tract, accompanied by pain of spastic origin. Contraindications Hypersensitivity to belladonna or any other component of the drug; diseases of the cardiovascular system, in which an increase in heart rate may be undesirable: atrial fibrillation, tachycardia, chronic heart failure, coronary heart disease, mitral stenosis, severe arterial hypertension; diseases of the gastrointestinal intestinal tract, accompanied by obstruction, hypoacid gastritis, urinary retention or a tendency to it, glaucoma, myasthenia gravis, hyperthermic syndrome, thyrotoxicosis, acute bleeding. Do not exceed the recommended doses of the drug. When using the drug, you should refrain from drinking alcoholic beverages. It should be used with caution in patients: with autonomic (autonomous) neuropathy; with prostatic hypertrophy without obstruction of the urinary tract; with Down’s disease, with cerebral palsy, brain damage; with liver and kidney failure; with chronic lung diseases, accompanied by low sputum production, which difficult to separate, especially in debilitated patients; with reflux esophagitis, hiatal hernia, combined with reflux esophagitis; with inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease; with megacolon; with xerostomia (dry mouth), elderly patients age or debilitated patients. At high ambient temperatures, the use of Becarbon can lead to heat stroke. Do not use the drug longer than the prescribed period without consulting a doctor! If the signs of the disease do not begin to disappear, or, conversely, the state of health worsens, or adverse events appear, then the patient should stop taking the drug and seek medical advice regarding further use. Use during pregnancy or lactation Use during pregnancy is possible only if, in the opinion of the doctor, the expected benefit to the mother outweighs the potential risk to the fetus. If necessary, the use of the drug breast-feeding should be discontinued. The ability to influence the reaction rate when driving vehicles or working with other mechanisms When using the drug, you should refrain from driving vehicles or working with other mechanisms due to possible side effects from the nervous system, organs of vision. Children Clinical data on the efficacy and safety of children are not available, therefore, Becarbon should not be prescribed to this category of patients. Elderly patients Geriatric patients are particularly susceptible to antimuscarinic effects (eg, constipation, dry mouth, urinary retention). Confusion and/or agitation is especially likely in this age group of patients. The occurrence of excitation, agitation, drowsiness is possible even at low dosages. Interaction with other drugs and other forms of interaction If you are taking any other drugs, be sure to tell your doctor! When using Becarbon: with amantadine, antiarrhythmic anticholinergic drugs (including quinidine), tricyclic antidepressants, nefopam, glutethimide – the anticholinergic effects of Becarbon are enhanced; with opioid analgesics and drugs that depress the central nervous system (including phenothiazines) – there is a dangerous overload of the central nervous system; with butyrophenones (haloperidol) and organic nitrates – intraocular pressure increases; with corticosteroids for systemic use – the effect of corticosteroids decreases and intraocular pressure may increase; with pilocarpine – its effect in the treatment of glaucoma decreases; with M-cholinergic blockers – anticholinergic effects increase; with furosemide – orthostatic hypotension is possible; with reserpine, MAO inhibitors, guanethidine, antacids, ascorbic acid, attapulgite – the effect of Becarbon is reduced; with levodopa – a decrease in systemic concentrations of levodopa, therefore, following due to adjust its dosage; with some antihistamines (including meclizine) – the antihistamine effect is enhanced; with beta-adrenergic blockers – their effect is reduced; with hormonal contraceptives – the contraceptive effect is reduced; with non-selective inhibitors of neuronal reuptake of monoamines – the sedative effect of both drugs is enhanced; with non-steroidal anti-inflammatory drugs, griseofulvin, digitoxin, doxycycline, metoclopramide, metronidazole – the effect of these drugs decreases; with ketoconazole – an increase in the pH of gastric juice with Becarbon reduces the absorption of ketoconazole, so Becarbon should be taken no earlier than 2 hours after taking ketoconazole; with sulfonamides – increases risk of kidney damage; with indapamide, nizatidine – their effect increases; with potassium chloride – damage to the mucous membrane of the gastrointestinal tract is possible; with domperidone – the effects of anticholinergic drugs are antagonistic to the effects of domperidone and on gastrointestinal activity; with lithium – sodium bicarbonate increases the excretion of lithium, reducing its concentration in the blood plasma. Since sodium bicarbonate, which is part of the drug, has antacid properties, it is advisable not to take Becarbon simultaneously with other drugs (their absorption may be impaired) . Method of application and dosage Apply to adults inside 30-40 minutes before meals, 1 tablet 2-3 times a day. Swallow the tablet without chewing and drink plenty of water. The use of the lowest possible effective doses is recommended. The highest single dose is 5 tablets. Becarbon is intended for symptomatic short-term use, so the duration of treatment should be selected individually. If the symptoms of the disease do not disappear within 3-5 days, you should consult a doctor to review the treatment regimen and regarding the further use of the drug. OverdoseSymptoms: increased manifestations of adverse reactions, nausea, vomiting, tachycardia, lowering blood pressure, agitation, irritability, tremor, convulsions, insomnia, drowsiness, hallucinations, hyperthermia, tachypnea and hyperpnea, signs of dehydration, depression of the central nervous system, depression of respiratory and vasomotor centers. Treatment: gastric lavage, activated charcoal, correction of water and electrolyte balance, parenteral administration of cholinomimetics and anticholinesterase agents. Treatment is symptomatic. At the first symptoms of an overdose, you should immediately seek medical help! Side effects Nervous system: headache, dizziness, nervousness, drowsiness, agitation (especially in older patients), weakness, sleep disorders, ataxia (disorders of movement coordination), speech disturbance. Urinary system: difficulty and retention of urination. Digestive tract: dry mouth, thirst, taste disturbance, belching, dysphagia, flatulence, abdominal cramps / pain, decreased intestinal motility up to atony, constipation, decreased tone of the biliary tract and gallbladder; when taking the drug in high doses for a short period of time, compensatory hypersecretion of gastric juice may occur. Organs of vision: dilated pupils, photophobia, accommodation paralysis, blurred vision, increased intraocular pressure. Cardiovascular system: reddening of the face, hot flashes, palpitations, arrhythmias (including extrasystole, tachycardia), myocardial ischemia, an increase in blood pressure is possible. Respiratory system and mediastinal organs: decrease in secretory activity and tone of the bronchi, leading to the formation of viscous sputum, which is difficult to expectorate. Immune system: possible manifestations of hypersensitivity reactions, including anaphylactic reactions, anaphylactic shock. Skin and subcutaneous tissue: skin rash, hyperemia, urticaria, exfoliative dermatitis. Other: decreased sweating, dry skin and mucous membranes, dysarthria, edema, increased existing hypokalemia. In the event of any negative reactions, the patient should definitely consult a doctor regarding the further use of the drug! Shelf life 3 years. Do not use the drug after the expiration date indicated on the package. Storage conditions In the original packaging to protect from light at a temperature not exceeding 25 °C. Keep out of the reach of children. Packing: 10 tablets in a blister made of PVC film and aluminum foil coated on one side with thermal varnish and printed on the other side, 2 blisters each with instructions for medical use of the drug or leaflet in a cardboard pack. Terms of saleWithout a prescription. Buy Becarbon tablets No. 10×2 Price for Becarbon tablets No. 10×2 Instructions for use for Becarbon tablets No. 10×2